Proliferative Vitreoretinopathy Market to Witness High and Share Acceleration During 2018-2027
With the rise in emphasis on prevention and treatment of proliferative vitreoretinopathy (PVR), a serious ailment that leads to blindness despite repeated treatment, the requirement for vitreoretinal centers has gained importance worldwide. Prevention of PVR development at early stage RRD for preserving visual function in patients has become a primary agenda among medical researchers and clinicians. A recent Fact.MR analysis envisages the ProliferativeVitreoretinopathy to reflect a modest 4.0% CAGR during the forecast period (2018-2027).
View full press release